期刊文献+

耐碳青霉烯类肠杆菌科细菌的分布及耐药性分析 被引量:7

Strains Distribution and Drug Resistance Analysis of Carbapenem-resistant Enterobacteriaceae
下载PDF
导出
摘要 目的:分析耐碳青霉烯类肠杆菌科细菌的分布情况及耐药性。方法:收集丽水市中心医院2010年12月~2013年6月临床分离的耐药菌株,采用法国梅里埃Vitek-2 compact细菌鉴定仪鉴定细菌,药物敏感性试验采用纸片扩散法(K-B法)。结果:共收集耐药菌株83株,其中肺炎克雷伯菌占68.67%,产气肠杆菌和阴沟肠杆菌各6.02%,大肠埃希菌2.41%。标本来源最常见为痰液(80.72%),其次尿液(8.43%)和分泌物(4.82%),科室分布最多者为重症监护病房(39.76%),其次为神经外科(36.51%)。74例患者在检测出耐药菌株前1个月内使用过至少一种抗菌药。有69.88%和31.33%的患者使用过哌拉西林/他唑巴坦和头孢哌酮/舒巴坦,15.66%和10.84%使用过亚胺培南/西司他丁和美罗培南。耐药菌株对多黏菌素B高度敏感,对米诺环素和阿米卡星的耐药率为13.25%和28.92%,对其他抗菌药的耐药率多介于70%~100%。结论:耐碳青霉烯类肠杆菌科细菌在医院重症监护病房和神经外科相对集中,对多数临床常用抗菌药呈高度耐药,给临床治疗带来严重的挑战。医院应做好院感监测,合理使用抗菌药,从而有效预防和控制耐药菌株的产生和传播。 Objective: To study the distribution and susceptibility of carbapenem-resistant Enterobacteriaceae (CRE) isolates in Lishui central hospital. Methods: Strains of CRE were collected from December 2010 to June 20!3 in Lishui central hospital. Strains were detected by Vitek-2 compact and the antimicrobial susceptibility testing were carried out using Kirby-Bauer method. Results: Eighty-three strains of CR.E were collected, of which Klebsiella p~umonia, Enter- obacter cloacae, Enterobacter aerogenes and Escherichia coli accounted for 68.67% ,6.02% ,6.02% and 2.41%. The iso- lated rate from sputum, urine and secretion were 80.72% ,8.43% and 4.82%. The distribution rates of CRE in Intensive Care Unit (ICU) and neurosurgery department were 39.76% and 36.51%. 74 patients used at least one kind of antimicro- bial in a month before CRE was detected, 69.88% of patients have used piperacillin/tazobactam, while cefoperazone/sul- bactam was 31.33%. 15.66% and 10.84% of patients have used imipenem/cilastatin and meropenem. All isolates were sensitive to polymyxin B. The resistance rate of CRE isolates to most of antimicrobial agents was 70% -100% except mino- cycline( 13.25% ) and amikacin(28.92% ). Conclusion: The CRE isolates were mainly isolated from specimen of sputum in ICU and neurosurgery department. It takes serious challenge to the clinical treatment because the antibiotic resistance of CRE isolates is much higher. So according to susceptibility test, the hospital should enhance the drug-resistance surveillance and use antibiotics reasonable to control the multi-drug resistance and the prevalence of resistant strains.
机构地区 丽水市中心医院
出处 《药物流行病学杂志》 CAS 2014年第10期608-611,共4页 Chinese Journal of Pharmacoepidemiology
基金 丽水市科学技术局科技项目(编号:2012ZC026)
关键词 碳青霉烯类药 肠杆菌科细菌 耐药监测 药物敏感试验 医院感染 Carbapenem Enterobacteriaceae Drug-resistance surveillance Antimicrobial susceptibility Nosocomial infection
  • 相关文献

参考文献15

  • 1Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twentieth-two informational supplement [ S ]. CLSI/NCCLS document M100- S22. PennsyIvania: Clinical and Laboratory Standards Insti- tute, 2012.
  • 2Queenan AM, Bush K. Carbapenemases:the versatile beta- lactamases [ J ]. Clin Microbiol Rev ,2007,20 (3) :440-458.
  • 3Oteo J, Delgado-Iribarren A, Vega D, et al. Emergence of imipenem resistance in clinical Escherichia coli during thera- py[ J]. Int Jantimicrob Agents ,2008,32(6) :534-537.
  • 4Qi Y, Wei ZQ, Ji SJ, et al. ST11, the dominant clone of KPC-producing Klehsiella pneumoniae in China [ J ]. J Antimicrob Chemother, 2011, 66(2) :307-312.
  • 5黄金伟,黄建胜,陈海泉,李国雄,余方友,任建敏.浙江省丽水地区发现1株泛耐药产KPC-2碳青霉烯酶的肺炎克雷伯菌[J].疾病监测,2011,26(1):58-60. 被引量:5
  • 6Hirsch EB, Tam VH. Detection and treatment options for Klebsiella .pneumoniae carbapenemases (KPCs) : an emerging cause of muhidrug-resistant infection [ J ]. J Antimicrob Che- mother,2010,65 (6) :1119-1125.
  • 7Endimiani A, Patel G, Hujer KM, et al. In vitro activity of fosfomycin against blaKPC-Containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline [ J ]. Antimicrob Agents Chemother,2010,54 ( 1 ),526-529.
  • 8Yigit H, Queenan AM, Anderson GJ, et al. Novel carbap- enem-hydrolyzing beta-lactamase, KPC-1, from a carbapen- em-resistant strain of Klebsiella pneumoniae [ J ]. Antimicrob Agents Chemother , 2001, 4 5 ( 4 ) :1151-1161.
  • 9杨青,邹燕萍,单志明,魏泽庆,沈萍,孔海深,俞云松.联合使用抗菌药物对产KPC-2酶肺炎克雷伯菌的影响[J].中华检验医学杂志,2011,34(11):984-987. 被引量:9
  • 10冯堃,姚源,黄伟,高玲.42例产碳青霉烯酶肺炎克雷伯菌感染患者的调查分析[J].中华医院感染学杂志,2011,21(3):563-565. 被引量:5

二级参考文献19

  • 1张幸国,杜小幸,张嵘,魏泽庆,俞云松,陈亚岗,李兰娟.发现一株产KPC-2型碳青霉烯酶肺炎克雷伯菌[J].中华检验医学杂志,2006,29(9):824-826. 被引量:60
  • 2Millan AB, Dominguez MA, Borraz C, et al. Community-onset and nosocomial bacteremia due to methicillin-resistant Staphylococcusaureus in Spanish hospitals[J].Enferm Infecc Mi crobiol Clin,2010,28(6) :336 -341.
  • 3Hossain A, Ferraro M J, Pino RM, et al. Plasmid-Mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp[J]. Antimicrob Agents Chemother,2004,48 ( 11 ) :4438 - 4440.
  • 4Yan J J, KO WC, Wu JJ. Identification of a plasmid encoding SHV- 2,TEM-1,and a variant of IMP-2 Metallo-β-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae [J ]. Antimierob Agents Chemother,2001,45 (8) :2368 - 2371.
  • 5Endimiani A,Patel G, Hujer KM,et al. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsuscepfible to tigecycline and/or colistin [ J 1- Antimicrob Agents Chemother,2004,54( 1 ) :526 -529.
  • 6胡付品,叶信予,吴培澄,吴湜,朱德妹,汪复.2005年上海华山医院细菌耐药性监测[J].中国感染与化疗杂志,2007,7(4):233-237. 被引量:58
  • 7Shen P, Wei Z, Jiang Y,et al. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother,2009,53:4333-4338.
  • 8Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis ,2009, 9:228-236.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twentieth Information Supplement. Wayne : CLSI 2010, MIO0-S20.
  • 10Wei ZQ, Du XX, Yu YS,et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother,2007, 51:763-765.

共引文献15

同被引文献46

引证文献7

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部